Correction
In the course of type-setting this article [1] for final publication the presentation of the data in Tables 1 and 2 was altered. To avoid any confusion and to improve the clarity of our results the corrected Tables are included here.
Table 1
Demographic and disease characteristics of patients who underwent full baseline assessment
All subjects | ||||||
|---|---|---|---|---|---|---|
(N = 15) | ||||||
Completed | Withdrawn | |||||
(N = 10) | (N = 5) | P | ||||
Mean (SD)
| ||||||
Age
| (yrs) | 67.9 (9.4) | 67.6 (10.9) | 68.4 (6.3) | 0.88 | |
Body mass index
| (kg/m2) | 23.1 (4.6) | 23.7(4.9) | 22.1(4.2) | 0.52 | |
N (%)
| ||||||
Sex
| ||||||
M | 9 (60) | 4 (40) | 5 (100) | |||
F | 6 (40) | 6 (60) | 0 (0) | 0.04 | ||
PS
| ||||||
1 | 2 (13) | 2 (20) | 0 (0) | |||
2 | 6 (40) | 4 (40) | 2 (40) | |||
3 | 7 (47) | 4 (40) | 3 (60) | 0.79 | ||
Diagnosis
| ||||||
Lung Cancer | 4 (27) | 3 (30) | 1 (20) | |||
GI cancer | 6 (40) | 2 (20) | 4 (80) | |||
Other | 5 (33) | 5 (50) | 0 (0) | NA | ||
Cancer stage
| ||||||
III | 1 (7) | 1 (10) | 0 (0) | |||
IV | 11 (73) | 6 (60) | 5 (100) | |||
NA | 3 (20) | 3 (30) | 0 (0) | NA | ||
Chemotherapy
| ||||||
Y | 10 (67) | 6 (60) | 4 (80) | |||
N | 5 (33) | 4 (40) | 1 (20) | 0.60 | ||
Recent steroid use
| ||||||
Y | 6 (40) | 4 (40) | 2 (40) | |||
N | 9 (60) | 6 (60) | 3 (60) | 1.00 | ||
Table 2
Physical performance evaluation results at baseline and after 6 weeks of NMES intervention
Baseline | End of study | ||||||||
|---|---|---|---|---|---|---|---|---|---|
All subjects | |||||||||
(N = 15) | |||||||||
Withdrawn | Completed | Completed | |||||||
(N = 5) | (N = 10) | Pa
| (N = 10) | Difference | Pb
| ||||
Number
| |||||||||
PS
| 1 | 0 | 2 | 0.79#
| 4 | 0.15#
| |||
2 | 2 | 4 | 4 | ||||||
3 | 3 | 4 | 2 | ||||||
Mean (SD)
| |||||||||
6MWT
| m | 257(160) | 166 (138) | 303 (157) | 0.11 | 282 (171) | −21.1 (167.7) | 0.70 | |
% | 50.2 (32.2) | 31.0(24.6) | 59.8(32.2) | 0.08 | 56.0(34.5) | −3.8 (33.3) | 0.73 | ||
STS
| s | 8.0(4.3) | 7.6 (3.4) | 8.2 (4.8) | 0.80 | 7.0(3.3) | −1.2 (3.4) | 0.30 | |
S-score | 2.6(2.4) | 2.2 (2.0) | 2.7 (2.2) | 0.69 | 2.0(1.8) | −0.7 (2.0) | 0.30 | ||
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.